Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012)

Dasmahapatra Girija; Lembersky Dmitry; Son Minkyeong P.; Patel Hiral; Peterson Derick; Attkisson Elisa; Fisher Richard I.; Friedberg Jonathan W.; Dent Paul; Grant Steven

首页> 外文期刊>Molecular cancer therapeutics >Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012)

【24h】

Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012)

机译：Obatoclax在体外和体内在GC-和ABC-DLBCL细胞中使用不可逆的蛋白酶体抑制剂Carfilzomib与不可逆的蛋白酶体抑制剂CarfiLzomib（缩回第11卷，PG 1122,2012）之间的相互作用。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Molecular cancer therapeutics》 |2019年第6期|共1页
作者
Dasmahapatra Girija; Lembersky Dmitry; Son Minkyeong P.; Patel Hiral; Peterson Derick; Attkisson Elisa; Fisher Richard I.; Friedberg Jonathan W.; Dent Paul; Grant Steven;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012) [J] . Dasmahapatra Girija, Lembersky Dmitry, Son Minkyeong P., Molecular cancer therapeutics . 2019,第6期

机译：Obatoclax在体外和体内在GC-和ABC-DLBCL细胞中使用不可逆的蛋白酶体抑制剂Carfilzomib与不可逆的蛋白酶体抑制剂CarfiLzomib（缩回第11卷，PG 1122,2012）之间的相互作用。
2. In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells (Retraction of Vol 13, Pg 2886, 2014) [J] . Dasmahapatra Girija, Patel Hiral, Friedberg Johnathan, Molecular cancer therapeutics . 2019,第6期

机译：在非霍奇金淋巴瘤细胞中的HDAC6抑制剂里吡喹酮（ACY1215）与不可逆蛋白酶体抑制剂Carfilzomib（Vol 13，PG 2886,2014的收缩）之间的体外和体内相互作用
3. Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo (Retraction of Vol 10, Pg 1686, 2011) [J] . Dasmahapatra Girija, Lembersky Dmitry, Son Minkyeong P., Molecular cancer therapeutics . 2019,第6期

机译：Carfilzomib在体外和体内在地幔细胞淋巴瘤细胞中协同互动地与组蛋白脱乙酰酶抑制剂（Rtreaction of Vol 10，PG 1686,1211）。
4. Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo [C] . Laurent Grossin, Stephanie Etienne, Nadege Gaborit, International Symposium on Mechanobiology of Cartilage and Chondrocyte . 2004

机译：通过蛋白酶体抑制剂Mg 132诱导热休克蛋白70（Hsp70），在体外和体内保护特性软骨细胞免受细胞死亡的影响
5. Retraction: Obatoclax Interacts Synergistically with the IrreversibleProteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells InVitro and In Vivo [O] . Girija Dasmahapatra, Dmitry Lembersky, Minkyeong P. Son, -1

机译：缩回：Obatoclax与不可逆转协同相互作用蛋白酶体抑制剂卡非佐米在GC-和ABC-DLBCL细胞中体外和体内
6. THE SECOND GENERATION PROTEASOME INHIBITOR CARFILZOMIB INTERACTS SYNERGISTICALLY WITH HDAC INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMA CELLS THROUGH MULTIPLE MECHANISMS AND CIRCUMVENTS BORTEZOMIB RESISTANCE [O] . Lembersky Dmitry 2009

机译：第二代抑菌剂卡非昔布与HDAC抑制剂协同作用，通过多种机制和环孢菌抗性扩散了大型B细胞淋巴瘤细胞

Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo (Retraction of Vol 11, Pg 1122, 2012)

著录项

相似文献

相关主题

期刊订阅